2018
DOI: 10.1016/j.rbmo.2017.10.114
|View full text |Cite
|
Sign up to set email alerts
|

Circulating irisin in patients with polycystic ovary syndrome: a meta-analysis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
26
0

Year Published

2018
2018
2024
2024

Publication Types

Select...
9

Relationship

2
7

Authors

Journals

citations
Cited by 24 publications
(27 citation statements)
references
References 45 publications
1
26
0
Order By: Relevance
“…Previous studies have shown that circulating ZAG, Irisin and Betatrophin concentrations were significantly reduced or elevated in patients with T2DM or PCOS, respectively, and were associated with IR [10][11][12][20][21][22]. In addition, a recent meta-analysis and other populations had indicated that serum irisin concentration in PCOS women were higher than that in healthy women, this elevaluation could be partly attributed to the BMI in PCOS patients [23][24][25][26]. Therefore, most studies have revealed that circulating Irisin levels indeed has a tendency to increase in PCOS women.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Previous studies have shown that circulating ZAG, Irisin and Betatrophin concentrations were significantly reduced or elevated in patients with T2DM or PCOS, respectively, and were associated with IR [10][11][12][20][21][22]. In addition, a recent meta-analysis and other populations had indicated that serum irisin concentration in PCOS women were higher than that in healthy women, this elevaluation could be partly attributed to the BMI in PCOS patients [23][24][25][26]. Therefore, most studies have revealed that circulating Irisin levels indeed has a tendency to increase in PCOS women.…”
Section: Discussionmentioning
confidence: 99%
“…In PCOS patients, circulating ZAG levels were reported to be consistently reduced [10,27,28]. However, the relationship between circulating betatrophin levels and PCOS is controversial and the studies in the literature are inconsistent [20][21][22][23][24][25][26][27][28][29][30][31][32][33][34]. Growing evidence indicates that these cytokines have some roles in the pathogenesis of T2DM and PCOS, and are also involved in IR development.…”
Section: Discussionmentioning
confidence: 99%
“…For studies reporting standard errors, 95% confidence intervals (CIs), or interquartile ranges, the standard deviations were obtained using the methods described in Cochrane Handbook for Systematic Reviews [ 29 ] or reported previously [ 30 ]. For studies including two different exercise training interventions, the control group was split into two groups with smaller sample sizes, aiming to provide reasonably independent comparisons and to overcome the unit-of-analysis error [ 29 ].…”
Section: Methodsmentioning
confidence: 99%
“…In women with PCOS, the evidence about irisin regulation remains largely conflicting (21,22,23). A study found high serum irisin levels when hyperandrogenism was part of the PCOS phenotype (21), but a recent meta-analysis showed that, with adjustment for BMI, circulating irisin levels are similar in PCOS patients and healthy controls (22). In addition, BAT activity had not been previously assessed in women with PCOS, and we hypothesized that BAT activity and its relation with irisin might be a novel metabolic pathway disrupted in PCOS, with implications for the development of future treatments.…”
Section: Introductionmentioning
confidence: 99%